Campbell & CO Investment Adviser LLC Cyma Bay Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.63 - $24.47 $181,884 - $352,392	-14,401 Reduced 39.88%	21,714 $512,000
Q3 2023 Nov 08, 2023	SELL	$10.86 - $17.62 $872,318 - $1.42 Million	-80,324 Reduced 68.98%	36,115 $538,000
Q2 2023 Aug 11, 2023	BUY	$7.47 - $10.95 $276,091 - $404,712	36,960 Added 46.5%	116,439 $1.28 Million
Q1 2023 May 11, 2023	BUY	$5.88 - $9.59 $467,336 - $762,203	79,479 New	79,479 $693,000
Q4 2020 Feb 09, 2021	SELL	$5.73 - $9.03 $193,674 - $305,214	-33,800 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$3.32 - $7.24 $112,216 - $244,712	33,800 New	33,800 $245,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.